Massimo Breda is an experienced professional in the fields of preclinical sciences and compliance, currently serving as Vice President of Preclinical Sciences & GLP/GCP compliance at Evotec since April 2020. Prior to this role, Massimo held the position of Scientific Director in the same field at Aptuit, an Evotec Company, from July 2018 to April 2020, and served as Head of Bioanalysis and DMPK Department at Aptuit from December 2013 to June 2018. Massimo's extensive career began at Accelera, where from September 1989 to December 2013, the individual was Head of the bioanalytical group. Massimo Breda holds a degree from Università di Pavia.
This person is not in the org chart
This person is not in any teams
This person is not in any offices